Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Hertenstein, Bernd
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Giesen N
,
Busch E
,
Schalk E
,
Beutel G
,
Rüthrich MM
,
Hentrich M
,
Hertenstein B
,
Hirsch HH
,
Karthaus M
,
Khodamoradi Y
, et al.
AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants.
Eur J Cancer. 2022;181:102-118.
PubMed
Google Scholar
Denkinger CM
,
Janssen M
,
Schäkel U
,
Gall J
,
Leo A
,
Stelmach P
,
Weber SF
,
Krisam J
,
Baumann L
,
Stermann J
, et al.
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial.
Nat Cancer. 2022.
PubMed
Google Scholar
Straka C
,
Liebisch P
,
Salwender H
,
Hennemann B
,
Metzner B
,
Knop S
,
Adler-Reichel S
,
Gerecke C
,
Wandt H
,
Bentz M
, et al.
Autotransplant with and without induction chemotherapy in older multiple myeloma patients: long-term outcome of a randomized trial.
Haematologica. 2016.
PubMed
Google Scholar
F
Fuchs M
,
Jacob ASophie
,
Kaul H
,
Kobe C
,
Kuhnert G
,
Pabst T
,
Greil R
,
Bröckelmann PJ
,
Topp MS
,
Just M
, et al.
Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma.
Leukemia. 2023.
PubMed
Google Scholar
G
Schlenk RF
,
Paschka P
,
Krzykalla J
,
Weber D
,
Kapp-Schwoerer S
,
Gaidzik VI
,
Leis C
,
Fiedler W
,
Kindler T
,
Schroeder T
, et al.
Gemtuzumab Ozogamicin in -Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study.
J Clin Oncol. 2019:JCO1901406.
PubMed
Google Scholar
Stadler M
,
Hambach L
,
Dammann E
,
Diedrich H
,
Kamal H
,
Hamwi I
,
Schultze-Florey C
,
Varvenne M
,
Ehrlich S
,
Buchholz S
, et al.
The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease.
Ann Hematol. 2023.
PubMed
Google Scholar
K
Gowdavally S
,
Tsamadou C
,
Platzbecker U
,
Sala E
,
Valerius T
,
Klein S
,
Kröger N
,
Wulf G
,
Einsele H
,
Thurner L
, et al.
KIR2DS4 and its variant KIR1D in KIR-AA genotype donors showed differential survival impact in patients with lymphoid disease after HLA-matched unrelated hematopoietic stem cell transplantation.
Transplant Cell Ther. 2023.
PubMed
Google Scholar